EAT is up +49.38%% since April’24 pick View All Top Buy Picks
Currently predicting for Mon, 1 Jul 2024

Trading levels for RVVTF

Fibonacci Support & Resistance Levels

Level Price
R3 0.0082 9.78%
R2 0.0080 6.72%
R1 0.0079 4.83%
Price 0.0075
S1 0.0074 -1.28%
S2 0.0073 -3.17%
S3 0.0070 -6.22%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.0075
S1 0.0070 -6.67%
S2 0 -
S3 0 -

RVVTF Predictions History

2 years ago
RamboRex3000 predicted that RVVTF for 2021-08-17 is going $0.310 (-4.23%)

2 years ago
JS predicted that RVVTF for 2021-08-16 is going $0.343 (5.96%)

2 years ago
JPower predicted that RVVTF for 2021-08-16 is going

Rank:

3 years ago
JS predicted that RVVTF for 2020-12-17 is going $0.536 (-3.42%)

3 years ago
JS predicted that RVVTF for 2020-11-18 is going $0.162 (-2.61%)

3 years ago
Austin Chaney predicted that RVVTF for 2020-11-18 is going $0.171 (2.80%)

Rank:

3 years ago
JS predicted that RVVTF for 2020-11-11 is going $0.141 (-11.88%)

3 years ago
JS predicted that RVVTF for 2020-11-10 is going $0.144 (-0.21%)

3 years ago
Austin Chaney predicted that RVVTF for 2020-11-10 is going

Rank:

3 years ago
JS predicted that RVVTF for 2020-10-29 is going $0.129 (-9.79%)

Click to get the best stock tips daily for free!

About Revive Therapeutics Ltd

Revive Therapeutics Ltd Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating ... RVVTF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT